Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $1.25M | +34.9K | +50.48% | $35.95 | 104K | Nov 1, 2021 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$360K | -2.08K | -2% | $173.00 | 102K | Nov 1, 2021 | Direct | F1, F2, F3 |
transaction | SGEN | Common Stock | Sale | -$451K | -2.59K | -2.54% | $174.20 | 99.3K | Nov 1, 2021 | Direct | F1, F2, F4 |
transaction | SGEN | Common Stock | Sale | -$132K | -753 | -0.76% | $175.08 | 98.5K | Nov 1, 2021 | Direct | F1, F2, F5 |
transaction | SGEN | Common Stock | Sale | -$1.56M | -8.78K | -8.91% | $177.29 | 89.8K | Nov 1, 2021 | Direct | F1, F2, F6 |
transaction | SGEN | Common Stock | Sale | -$2.57M | -14.5K | -16.1% | $178.07 | 75.3K | Nov 1, 2021 | Direct | F1, F2, F7 |
transaction | SGEN | Common Stock | Sale | -$1.11M | -6.22K | -8.26% | $179.14 | 69.1K | Nov 1, 2021 | Direct | F1, F2, F8 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -34.9K | -100% | $0.00* | 0 | Nov 1, 2021 | Common Stock | 34.9K | $35.95 | Direct | F9 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 13, 2020. |
F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $172.50 to $173.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $173.59 to $174.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $174.71 to $175.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $176.72 to $177.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F7 | Reflects sales of common stock executed in multiple transactions at prices ranging from $177.72 to $178.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F8 | Reflects sales of common stock executed in multiple transactions at prices ranging from $178.80 to $179.34. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F9 | Options vested at a rate of 25% on 11/17/15 and monthly thereafter until all options were fully vested on 11/17/18. |